← Back to home

PHILADELPHIA CHROMOSOME NEGATIVE B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA

Clinical trials for PHILADELPHIA CHROMOSOME NEGATIVE B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA explained in plain language.

Never miss a new study

Get alerted when new PHILADELPHIA CHROMOSOME NEGATIVE B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA trials appear

Sign up with your email to follow new studies for PHILADELPHIA CHROMOSOME NEGATIVE B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

New injection method could replace IV drips for leukemia patients

Disease control Not yet recruiting

This study is testing whether giving a leukemia drug called blinatumomab as a simple injection under the skin works as well as giving it through a continuous IV drip. It will involve 560 adults newly diagnosed with a specific type of acute lymphoblastic leukemia who are already i…

Matched conditions: PHILADELPHIA CHROMOSOME NEGATIVE B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA

Phase: PHASE3 • Sponsor: Amgen • Aim: Disease control

Last updated Mar 20, 2026 14:48 UTC

PHILADELPHIA CHROMOSOME NEGATIVE B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA

Get alerted when new PHILADELPHIA CHROMOSOME NEGATIVE B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA trials appear

New injection method could replace IV drips for leukemia patients